Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
J Clin Endocrinol Metab
    April 2024
  1. TODA S, Hiroshima Y, Iwasaki H, Masudo K, et al
    Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan.
    J Clin Endocrinol Metab. 2024 Apr 17:dgae271. doi: 10.1210.
    >> Share

  2. SAKO A, Matsuse M, Saenko V, Tanaka A, et al
    TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae220. doi: 10.1210.
    >> Share

    March 2024
  3. HENSLEY SG, Hu MI, Bassett RL, Ying AK, et al
    Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades.
    J Clin Endocrinol Metab. 2024 Mar 4:dgae133. doi: 10.1210.
    >> Share

    February 2024
  4. JAGANNATH S, Mayilvaganan S
    Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma".
    J Clin Endocrinol Metab. 2024 Feb 29:dgae117. doi: 10.1210.
    >> Share

  5. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
    Response to Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?".
    J Clin Endocrinol Metab. 2024 Feb 28:dgae118. doi: 10.1210.
    >> Share

  6. MAINO F, Botte M, Dalmiglio C, Valerio L, et al
    Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
    J Clin Endocrinol Metab. 2024;109:722-729.
    >> Share

  7. STEGENGA MT, van Velsen EFS, Oudijk L, Verburg FA, et al
    Clinical and Histopathological Risk Factors for Radioactive Iodine Refractory Follicular and Oncocytic Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2024 Feb 13:dgae084. doi: 10.1210.
    >> Share

    December 2023
  8. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
    Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
    J Clin Endocrinol Metab. 2023;109:e347-e355.
    >> Share

    November 2023
  9. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Role of the degree of vascular invasion in predicting prognosis of follicular thyroid carcinoma.
    J Clin Endocrinol Metab. 2023 Nov 25:dgad689. doi: 10.1210.
    >> Share

  10. TORA R, Welch J, Sun J, Agarwal SK, et al
    Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
    J Clin Endocrinol Metab. 2023;108:3165-3177.
    >> Share

  11. LIU Q, Mao L, Zhang Z, Li G, et al
    Diagnostic Efficacy of FNA-Tg in DTC Cervical LN Metastasis and its Impact Factors: A Large Retrospective Study.
    J Clin Endocrinol Metab. 2023;108:3311-3319.
    >> Share

  12. FALCHETTI A
    New Perspective on the Genetic Dissection Underlying the Development of Parathyroid Cancer.
    J Clin Endocrinol Metab. 2023;108:e1751-e1752.
    >> Share

  13. LI P, Liu Y, Wei T, Wang X, et al
    Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
    >> Share

    October 2023
  14. KWON H, Han KD, Moon SJ, Park SE, et al
    Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210.
    >> Share

  15. DAI P, Zhao W, Zheng X, Luo H, et al
    Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant.
    J Clin Endocrinol Metab. 2023 Oct 7:dgad580. doi: 10.1210.
    >> Share


  16. Correction to "The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation".
    J Clin Endocrinol Metab. 2023 Oct 3:dgad573. doi: 10.1210.
    >> Share

    September 2023
  17. PALYGA I, Rumian M, Kosel A, Albrzykowski M, et al
    The frequency of differentiated thyroid cancer recurrence in 2302 patients with excellent response to primary therapy.
    J Clin Endocrinol Metab. 2023 Sep 28:dgad571. doi: 10.1210.
    >> Share

  18. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    >> Share

  19. POZDEYEV N, Dighe M, Barrio M, Raeburn C, et al
    Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant.
    J Clin Endocrinol Metab. 2023 Sep 8:dgad530. doi: 10.1210.
    >> Share

  20. ILGAN S, Aydogan BI, Emer O, Anil C, et al
    Sonographic features of atypical and initially missed parathyroid adenomas: Lessons learned from a single center cohort.
    J Clin Endocrinol Metab. 2023 Sep 5:dgad527. doi: 10.1210.
    >> Share

    August 2023
  21. GILLIS A, Chen H, Wang TS, Dream S, et al
    Racial and Ethnic Disparities in the Diagnosis and Treatment of Thyroid Disease: a Mini- Review.
    J Clin Endocrinol Metab. 2023 Aug 30:dgad519. doi: 10.1210.
    >> Share

  22. HA EJ, Lee JH, Lee DH, Moon J, et al
    Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: A Multicenter Diagnostic Study.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad503. doi: 10.1210.
    >> Share

  23. JU G, Sun Y, Wang H, Zhang X, et al
    Fusion oncogenes in patients with locally advanced or distant metastatic differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad500. doi: 10.1210.
    >> Share

  24. MACHENS A, Lorenz K, Brandenburg T, Fuhrer-Sakel D, et al
    The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine.
    J Clin Endocrinol Metab. 2023;108:e734-e742.
    >> Share

  25. LI H, Han R, Meng L, Sun Y, et al
    Nodal Metastases Associated with Fusion Oncogenes Are Age Dependent in Young Adult Patients with Thyroid Cancer.
    J Clin Endocrinol Metab. 2023 Aug 3:dgad458. doi: 10.1210.
    >> Share

  26. CETANI F, Pardi E, Torregrossa L, Borsari S, et al
    Approach to the Patient With Parathyroid Carcinoma.
    J Clin Endocrinol Metab. 2023 Aug 2:dgad455. doi: 10.1210.
    >> Share

    July 2023
  27. WANG JR, Zafereo ME, Wang W, Joshu C, et al
    Association of polygenic score with tumor molecular subtypes in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad407. doi: 10.1210.
    >> Share

  28. MERCADO M
    The Role of Androgen Receptors in Thyroid Cancer Biology: Beyond Sexual Dimorphism.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad424. doi: 10.1210.
    >> Share

  29. TIAN T, Qi Z, Huang S, Wang H, et al
    Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels.
    J Clin Endocrinol Metab. 2023;108:2033-2041.
    >> Share

  30. NOEL JE, Sinclair CF
    Radiofrequency Ablation for Benign Thyroid Nodules.
    J Clin Endocrinol Metab. 2023 Jul 4:dgad357. doi: 10.1210.
    >> Share

    June 2023
  31. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
    Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
    J Clin Endocrinol Metab. 2023 Jun 23:dgad369. doi: 10.1210.
    >> Share

  32. SHAHA AR
    Aggressive Subtypes of Papillary Microcarcinoma.
    J Clin Endocrinol Metab. 2023;108:e489-e490.
    >> Share

  33. XIANG P, Ahmadi S, Coleman A, West W, et al
    Identifying and Predicting Diverse Patterns of Benign Nodule Growth.
    J Clin Endocrinol Metab. 2023;108:e458-e463.
    >> Share

  34. TAO X, Xu T, Lin X, Xu S, et al
    Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    J Clin Endocrinol Metab. 2023;108:1768-1775.
    >> Share

  35. YAN L, Zhen Y, Li Y, Li X, et al
    Five-year Outcome Between Radiofrequency Ablation vs. Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad360. doi: 10.1210.
    >> Share

  36. YEH MW
    The molecular landscape of thyroid nodules: Diagnostic and prognostic revelations from a large multicenter cohort.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad362. doi: 10.1210.
    >> Share

  37. SATAPATHY S, Majeed AK, Ballal S, Bal C, et al
    Differentiated thyroid cancers in young adults versus children: Clinical characteristics and ten-year follow-up outcomes.
    J Clin Endocrinol Metab. 2023 Jun 7:dgad343. doi: 10.1210.
    >> Share

  38. SGRO D, Brancatella A, Greco G, Torregrossa L, et al
    Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad313. doi: 10.1210.
    >> Share

  39. ZHOU Y, Wang Y, Zhang Z, Yin X, et al
    Male sex is not a risk factor for prognosis in postoperative thyroid cancer patients: a propensity score matching study.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad314. doi: 10.1210.
    >> Share

  40. BOJARSKY M, Baran JA, Halada S, Isaza A, et al
    Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated with Radioactive Iodine Therapy.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad322. doi: 10.1210.
    >> Share

    May 2023
  41. LIN Y, Wu ZR, Shi YP, Ding M, et al
    Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.
    J Clin Endocrinol Metab. 2023 May 23:dgad269. doi: 10.1210.
    >> Share

  42. CHOU CK, Chi SY, Hung YY, Yang YC, et al
    Clinical impact of androgen receptor-suppressing miR-146b expression in papillary thyroid cancer aggressiveness.
    J Clin Endocrinol Metab. 2023 May 23:dgad279. doi: 10.1210.
    >> Share

  43. ALZAHRANI AS
    Clinical use of molecular data in thyroid nodules and cancer.
    J Clin Endocrinol Metab. 2023 May 18:dgad282. doi: 10.1210.
    >> Share

  44. NASR CE, Andrioli M, Endo M, Harrell RM, et al
    Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis.
    J Clin Endocrinol Metab. 2023;108:1526-1532.
    >> Share

  45. SUN Y, Sun Q, Tian J, He X, et al
    Impact of waiting time for radioactive iodine therapy on outcome in N1 stage papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 May 11:dgad264. doi: 10.1210.
    >> Share

    April 2023
  46. ULLMANN TM, Sosa JA
    Delay in Surgery for Papillary Thyroid Cancer: A Proxy for Lower-Quality Care?
    J Clin Endocrinol Metab. 2023 Apr 21:dgad232. doi: 10.1210.
    >> Share

  47. CHIOSEA S, Hodak SP, Yip L, Abraham D, et al
    Molecular Profiling of 50,734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.
    J Clin Endocrinol Metab. 2023 Apr 18:dgad220. doi: 10.1210.
    >> Share

    March 2023
  48. ALSWAILEM M, Alghamdi B, Alotaibi A, Aljomiah A, et al
    Molecular genetics of diffuse sclerosing papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad185. doi: 10.1210.
    >> Share

  49. KIM NE, Raghunathan RS, Hughes EG, Longstaff XR, et al
    Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210.
    >> Share

  50. ALZAHRANI AS
    The risk of expanding risk stratification in thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad182. doi: 10.1210.
    >> Share

  51. CHAVES N, Broekhuis JM, Fligor SC, Collins RA, et al
    Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: a SEER-Medicare Analysis.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad163. doi: 10.1210.
    >> Share

  52. VAN VELSEN EFS, Verburg FA
    Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer - To Treat or Not To Treat.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad171. doi: 10.1210.
    >> Share

  53. KESBY N, Mechera R, Fuchs T, Papachristos A, et al
    Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad173. doi: 10.1210.
    >> Share

  54. NASR CE
    Can one predict long-term growth of cytologically-benign thyroid nodules?
    J Clin Endocrinol Metab. 2023 Mar 22:dgad160. doi: 10.1210.
    >> Share

  55. JHA S, Welch J, Tora R, Lack J, et al
    Germline and somatic inactivating FLCN variants in parathyroid cancer and atypical parathyroid tumors.
    J Clin Endocrinol Metab. 2023 Mar 20:dgad136. doi: 10.1210.
    >> Share

    February 2023
  56. GRANI G, Del Gatto V, Cantisani V, Mandel SJ, et al
    A reappraisal of suspicious sonographic features of thyroid nodules: shape is not an independent predictor of malignancy.
    J Clin Endocrinol Metab. 2023 Feb 22:dgad092. doi: 10.1210.
    >> Share

  57. GRANI G, Gentili M, Siciliano F, Albano D, et al
    A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study.
    J Clin Endocrinol Metab. 2023 Feb 16:dgad075. doi: 10.1210.
    >> Share

  58. SEISA MO, Nayfeh T, Hasan B, Firwana M, et al
    A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults.
    J Clin Endocrinol Metab. 2023;108:585-591.
    >> Share

  59. PRETE A, Gambale C, Torregrossa L, Ciampi R, et al
    Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment.
    J Clin Endocrinol Metab. 2023 Feb 1:dgad061. doi: 10.1210.
    >> Share

    January 2023
  60. PRAW SS, Brent GA
    Approach to the Patient With a Suppressed TSH.
    J Clin Endocrinol Metab. 2023;108:472-482.
    >> Share

  61. CHOI JH, Lee JK, Kim W, Yu HW, et al
    Response to Letter to the Editor from Yang et al.: "Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers".
    J Clin Endocrinol Metab. 2023 Jan 6:dgac754. doi: 10.1210.
    >> Share

  62. YANG S, Tan M, Gao F, Xu X, et al
    Letter to the Editor from Yang et al.: "Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers".
    J Clin Endocrinol Metab. 2023 Jan 2:dgac753. doi: 10.1210.
    >> Share

    December 2022
  63. MAJEED AK, Satapathy S, Ballal S, Bal C, et al
    Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers.
    J Clin Endocrinol Metab. 2022 Dec 29:dgac731. doi: 10.1210.
    >> Share

  64. ZHANG X, Liu JR, Mu ZZ, Cheng XQ, et al
    Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in Intermediate-risk Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2022 Dec 26:dgac745. doi: 10.1210.
    >> Share

  65. LEE JS, Lee JS, Yun HJ, Kim SM, et al
    Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm.
    J Clin Endocrinol Metab. 2022 Dec 21:dgac739. doi: 10.1210.
    >> Share

  66. RANA C, Bychkov A
    NIFTP Statistics-Now You See It, Now You Don't.
    J Clin Endocrinol Metab. 2022;108:e5-e6.
    >> Share

  67. VAN VELSEN EFS, Peeters RP, Stegenga MT, van Kemenade FJ, et al
    Evaluating Disease Specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2022 Dec 12:dgac721. doi: 10.1210.
    >> Share

    November 2022
  68. PEREZ MN, Halada S, Isaza A, Sisko L, et al
    Health-Related Quality of Life at Diagnosis for Pediatric Thyroid Cancer Patients.
    J Clin Endocrinol Metab. 2022 Nov 4. pii: 6795528. doi: 10.1210.
    >> Share

  69. ULLMANN TM, Papaleontiou M, Sosa JA
    Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.
    J Clin Endocrinol Metab. 2022 Nov 3. pii: 6795262. doi: 10.1210.
    >> Share

  70. BROEKHUIS JM, James BC
    Delays in Surgery for Differentiated Thyroid Carcinomas: How Long is Reasonable, and What Questions Remain?
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785940. doi: 10.1210.
    >> Share

    October 2022
  71. TIAN T, Huang S, Dai H, Qi M, et al
    Radioactive Iodine-Refractory Pulmonary Metastases of Papillary Thyroid Cancer in Child, Adolescent, and Young Adult.
    J Clin Endocrinol Metab. 2022 Oct 13. pii: 6760001. doi: 10.1210.
    >> Share

  72. RIVKEES SA
    Approach to the Patient: Management and the Long-Term Consequences of Graves' Disease in Children.
    J Clin Endocrinol Metab. 2022 Oct 3. pii: 6746564. doi: 10.1210.
    >> Share

  73. MA B, Wen S, Luo Y, Zhang T, et al
    Targeting tumor hypoxia inhibits aggressive phenotype of dedifferentiated thyroid cancer.
    J Clin Endocrinol Metab. 2022 Oct 3. pii: 6747527. doi: 10.1210.
    >> Share

    September 2022
  74. ANGELL TE, Kwon DI
    Finding the Balance on Extent of Initial Thyroidectomy for Low-Risk Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Sep 22. pii: 6711571. doi: 10.1210.
    >> Share

  75. PALERMO A, Sodo A, Naciu AM, Gioacchino MD, et al
    Clinical use of Raman spectroscopy improves diagnostic accuracy for indeterminate thyroid nodules.
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6697971. doi: 10.1210.
    >> Share

  76. PALERMO A, Cesareo R
    Response to Letter to the Editor from Xu and Yang: Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules:12-Month Results of a Randomized Trial (LARA II Study).
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691130. doi: 10.1210.
    >> Share

  77. ZHOU H, Wu J, Shi L, Wang Y, et al
    Analysis of delayed surgery and clinical outcomes in intermediate- and high-risk papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691129. doi: 10.1210.
    >> Share

    August 2022
  78. MA X, Ma X, Chin L, Zhu Z, et al
    A Novel Germline Deletion of p.C630 in RET Causes MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib.
    J Clin Endocrinol Metab. 2022;107:2636-2643.
    >> Share

  79. ARROYO N, Bell KJL, Hsiao V, Fernandes-Taylor S, et al
    Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies.
    J Clin Endocrinol Metab. 2022 Aug 10. pii: 6659928. doi: 10.1210.
    >> Share

  80. CHEN DW, Rob FI, Mukherjee R, Giordano TJ, et al
    Variation in the diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    J Clin Endocrinol Metab. 2022 Aug 3. pii: 6653515. doi: 10.1210.
    >> Share

  81. CHOI JH, Lee JK, Kim W, Yu HW, et al
    Prevalence of Postoperatively-Detected High-Risk Features in 2-4cm Papillary Thyroid Cancers.
    J Clin Endocrinol Metab. 2022 Aug 1. pii: 6653085. doi: 10.1210.
    >> Share

    July 2022
  82. WANG X, Zheng X, Zhu J, Li Z, et al
    Radioactive iodine therapy does not improve cancer-specific survival in Hurthle cell carcinoma of the thyroid.
    J Clin Endocrinol Metab. 2022 Jul 31. pii: 6652584. doi: 10.1210.
    >> Share

  83. OMIDAKHSH N, Heck JE, Cockburn M, Ling C, et al
    Thyroid Cancer and Pesticide Use in a Central California Agricultural Area: A Case Control Study.
    J Clin Endocrinol Metab. 2022 Jul 26. pii: 6650257. doi: 10.1210.
    >> Share


  84. Correction to: Lenvatinib Targets PDGFR-beta Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
    J Clin Endocrinol Metab. 2022 Jul 8. pii: 6633918. doi: 10.1210.
    >> Share

    June 2022
  85. ALZAHRANI AS, Alswailem M, Alghamdi B, Al-Hindi H, et al
    Fumarate hydratase is a novel gene for familial non-medullary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 25. pii: 6618018. doi: 10.1210.
    >> Share

  86. WANG K, Liu S, Tian Y, Liu C, et al
    PDZK1 interacting protein 1 (PDZK1IP1) promotes the progression of papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 21. pii: 6612492. doi: 10.1210.
    >> Share

  87. SAVVATEEVA M, Kudryavtseva A, Lukyanova E, Kobelyatskaya A, et al
    Somatic Mutation Profiling in Head and Neck Paragangliomas.
    J Clin Endocrinol Metab. 2022;107:1833-1842.
    >> Share

  88. TSANG V, Gill A, Gild M, Lurie B, et al
    Selpercatinib treatment of RET mutated thyroid cancers is associated with gastrointestinal adverse effects.
    J Clin Endocrinol Metab. 2022 Jun 1. pii: 6596759. doi: 10.1210.
    >> Share

    May 2022
  89. ELISEI R, Ciampi R, Matrone A, Prete A, et al
    Somatic Ret Indels In Sporadic Medullary Thyroid Cancer: Prevalence And Response To Selpercatinib.
    J Clin Endocrinol Metab. 2022 May 25. pii: 6591888. doi: 10.1210.
    >> Share

  90. GLASGOW C, Lau EYC, Aloj L, Harper I, et al
    An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
    J Clin Endocrinol Metab. 2022;107:1706-1713.
    >> Share

  91. VIOLA D, Poma AM, Elisei R, Basolo F, et al
    Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2653-e2654.
    >> Share

  92. GREEN M, Gosmanov AR
    Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should Not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2647-e2648.
    >> Share

  93. SOE MH, Chiang JM, Flavell RR, Khanafshar E, et al
    Non-iodine Avid Disease is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer with Papillary Histology.
    J Clin Endocrinol Metab. 2022 May 12. pii: 6584960. doi: 10.1210.
    >> Share

  94. BURGOS N, Zhao J, Brito JP, Hoang JK, et al
    Clinician agreement on the classification of thyroid nodules ultrasound features: A survey of two endocrine societies.
    J Clin Endocrinol Metab. 2022 May 6. pii: 6581574. doi: 10.1210.
    >> Share

    April 2022
  95. CIAMPI R, Romei C, Ramone T, Matrone A, et al
    Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Apr 26. pii: 6574259. doi: 10.1210.
    >> Share

  96. VINCZE S, Peters NV, Kuo CL, Brown TC, et al
    GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2022;107:e2021-e2026.
    >> Share

  97. PAPPA T, Ahmadi S, Bikas A, Hwang S, et al
    Thyroid nodule shape independently predicts risk of malignancy.
    J Clin Endocrinol Metab. 2022 Apr 19. pii: 6570820. doi: 10.1210.
    >> Share

  98. PAPARODIS RD, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Large, slowly growing, benign thyroid nodules frequently coexist with synchronous thyroid cancers.
    J Clin Endocrinol Metab. 2022 Apr 18. pii: 6570003. doi: 10.1210.
    >> Share

  99. ULLMANN TM, Duh QY
    Isolated Lateral Neck Nodal Metastases in Patients with Papillary Thyroid Cancer: Does Cervical Compartment Matter?
    J Clin Endocrinol Metab. 2022 Apr 12. pii: 6567539. doi: 10.1210.
    >> Share

  100. HUANG L, Feng X, Yang W, Li X, et al
    Appraising the effect of potential risk factors on thyroid cancer: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Apr 2. pii: 6562772. doi: 10.1210.
    >> Share

    March 2022
  101. ZHAO ZL, Wei Y, Peng LL, Li Y, et al
    Recurrent Laryngeal Nerve Injury in Thermal Ablation of Thyroid Nodules - Risk Factors and Cause Analysis.
    J Clin Endocrinol Metab. 2022 Mar 21. pii: 6551221. doi: 10.1210.
    >> Share

  102. BOUCAI L, Tuttle RM
    Letter to the Editor from Boucai, L and Tuttle, RM: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545312. doi: 10.1210.
    >> Share

  103. XING M
    Response to Letter to the Editor from Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545262. doi: 10.1210.
    >> Share

    February 2022
  104. WENG HY, Yan T, Qiu WW, Fan YB, et al
    The prognosis of skip metastasis in papillary thyroid microcarcinoma is better than that of continuous metastasis.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537119. doi: 10.1210.
    >> Share

    January 2022
  105. ALEXANDER EK
    Novel Genomic Roadmaps and Their Clinical Translation Ahead.
    J Clin Endocrinol Metab. 2022;107:e886-e887.
    >> Share

  106. HAY ID, Lee RA, Charboneau JW
    Efficacy of ethanol ablation in long-term local control of neck nodal metastases in adult papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2022 Jan 14. pii: 6507732. doi: 10.1210.
    >> Share

  107. JANKOVIC MILJUS J, Guillen-Sacoto MA, Makiadi-Alvarado J, Wert-Lamas L, et al
    Circulating MicroRNA Profiles as Potential Biomarkers for differentiated thyroid cancer recurrence.
    J Clin Endocrinol Metab. 2022 Jan 11. pii: 6503735. doi: 10.1210.
    >> Share

    December 2021
  108. STAN MN, Papaleontiou M, Schmitz JJ, Castro MR, et al
    Non-surgical management of thyroid nodules - the role of ablative therapies.
    J Clin Endocrinol Metab. 2021 Dec 25. pii: 6483061. doi: 10.1210.
    >> Share

  109. ROTONDI M, Chiovato L
    Pre-existing or concomitant thyroiditis in papillary thyroid cancer: Something more than a mere issue of timing?
    J Clin Endocrinol Metab. 2021 Dec 20. pii: 6470727. doi: 10.1210.
    >> Share

  110. FRICH PS, Sigstad E, Berstad AE, Holgersen KF, et al
    Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Dec 18. pii: 6469671. doi: 10.1210.
    >> Share

  111. ASAMOAH EO, Caraballo G, Castro MR
    Identifying and addressing Health disparities in Thyroid Cancer Care.
    J Clin Endocrinol Metab. 2021 Dec 6. pii: 6454343. doi: 10.1210.
    >> Share

    November 2021
  112. BOUCAI L, Seshan V, Williams M, Knauf JA, et al
    Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
    J Clin Endocrinol Metab. 2021 Nov 23. pii: 6433608. doi: 10.1210.
    >> Share

  113. NIETO HR, Thornton CEM, Brookes K, de Menezes AN, et al
    Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.
    J Clin Endocrinol Metab. 2021 Nov 16. pii: 6429719. doi: 10.1210.
    >> Share

  114. WEI Y, Zhao ZL, Wu J, Peng LL, et al
    Response to Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427797. doi: 10.1210.
    >> Share

  115. YANG S, Xu X
    Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427798. doi: 10.1210.
    >> Share

  116. LI H, Zhou X, Wang G, Hua D, et al
    CAR-T cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Nov 9. pii: 6423845. doi: 10.1210.
    >> Share

    October 2021
  117. ROH E, Noh E, Hwang SY, Kim JA, et al
    Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: A nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Oct 28. pii: 6413717. doi: 10.1210.
    >> Share

  118. RADHAKRISHNAN A, Reyes-Gastelum D, Abrahamse P, Gay B, et al
    Physician specialties involved in thyroid cancer diagnosis and treatment: Implications for improving healthcare disparities.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6411790. doi: 10.1210.
    >> Share

  119. KOH J, Zhang R, Roman S, Duh QY, et al
    Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
    J Clin Endocrinol Metab. 2021;106:3168-3183.
    >> Share

  120. SAPONARO F, Pardi E, Mazoni L, Borsari S, et al
    Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
    J Clin Endocrinol Metab. 2021;106:e4565-e4579.
    >> Share

  121. NILUBOL N
    "Cutting the Support" to improve treatment efficacy in thyroid cancer by targeting tumor microenvironment.
    J Clin Endocrinol Metab. 2021 Oct 20. pii: 6406379. doi: 10.1210.
    >> Share

  122. BROSE MS, Panaseykin Y, Konda B, de La Fouchardiere C, et al
    A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Oct 19. pii: 6401965. doi: 10.1210.
    >> Share

  123. CHANDER NR, Chidambaram S, Van Den Heede K, DiMarco AN, et al
    Correlation of pre-operative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance.
    J Clin Endocrinol Metab. 2021 Oct 13. pii: 6395413. doi: 10.1210.
    >> Share

  124. GOLDFARB M, Christison-Lagay E, Rastatter J, Wasserman J, et al
    "Young children are not the same as adolescents when it comes to treating thyroid cancer".
    J Clin Endocrinol Metab. 2021 Oct 5. pii: 6381652. doi: 10.1210.
    >> Share

    September 2021
  125. SINGH P, Bhadada SK, Dahiya D, Saikia UN, et al
    GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    J Clin Endocrinol Metab. 2021;106:e4084-e4096.
    >> Share

  126. POMA AM, Viola D, Macerola E, Proietti A, et al
    Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
    J Clin Endocrinol Metab. 2021;106:e4109-e4117.
    >> Share

  127. LIN S, Zhu Y, Ji C, Yu W, et al
    METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375332. doi: 10.1210.
    >> Share

  128. KIM BW
    Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
    J Clin Endocrinol Metab. 2021 Sep 23. pii: 6374549. doi: 10.1210.
    >> Share

  129. DEKKER BL, Links MH, Muller Kobold AC, Swart-Busscher LG, et al
    Low iodine diet of four days is sufficient preparation for 131I therapy in differentiated thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Sep 17. pii: 6371836. doi: 10.1210.
    >> Share

    August 2021
  130. SINGH P, Bhadada SK, Arya AK, Saikia UN, et al
    Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis.
    J Clin Endocrinol Metab. 2021 Aug 28. pii: 6358989. doi: 10.1210.
    >> Share

  131. REDLICH A, Luster M, Lorenz K, Lessel L, et al
    Age, ATA risk group and response to therapy are prognostic factors in children with differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Aug 20. pii: 6355728. doi: 10.1210.
    >> Share

  132. GIOVANELLA L, Garo ML, Ceriani L, Paone G, et al
    Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 12. pii: 6348893. doi: 10.1210.
    >> Share

  133. HAYES AR, Crawford A, Al Riyami K, Tang C, et al
    Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
    J Clin Endocrinol Metab. 2021 Aug 11. pii: 6348246. doi: 10.1210.
    >> Share

  134. LEE EK, Ahn HY, Ku EJ, Yoo WS, et al
    Cardiovascular outcomes in thyroid cancer patients treated with thyroidectomy: A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 4. pii: 6339941. doi: 10.1210.
    >> Share

    July 2021
  135. CIAPPUCCINI R, Saguet-Rysanek V, Giffard F, Licaj I, et al
    PSMA expression in differentiated thyroid cancer: association with radioiodine, 18FDG uptake, and patient outcome.
    J Clin Endocrinol Metab. 2021 Jul 31. pii: 6332894. doi: 10.1210.
    >> Share

  136. IESATO A, Li S, Roti G, Hacker MR, et al
    Lenvatinib targets PDGFR-beta pericytes and inhibits synergy with thyroid carcinoma cells: novel translational insights.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327813. doi: 10.1210.
    >> Share

  137. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    >> Share

  138. TAO Y, Wang F, Shen X, Zhu G, et al
    BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 17. pii: 6323355. doi: 10.1210.
    >> Share

  139. GIANI C, Torregrossa L, Ramone T, Romei C, et al
    Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 3. pii: 6291802. doi: 10.1210.
    >> Share

  140. YANG S, Xu X
    Letter to the Editor from [Xiequn Xu]: (Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study)).
    J Clin Endocrinol Metab. 2021 Jul 1. pii: 6312741. doi: 10.1210.
    >> Share

    June 2021
  141. PAULSSON JO, Rafati N, DiLorenzo S, Chen Y, et al
    Whole-genome sequencing of follicular thyroid carcinomas reveal recurrent mutations in microRNA processing subunit DGCR8.
    J Clin Endocrinol Metab. 2021 Jun 25. pii: 6309631. doi: 10.1210.
    >> Share

  142. RADEBE L, van der Kaay DCM, Wasserman JD, Goldenberg A, et al
    Predicting Malignancy with Pediatric Thyroid Nodules: Early Experience in Machine Learning for Clinical Decision Support.
    J Clin Endocrinol Metab. 2021 Jun 23. pii: 6308313. doi: 10.1210.
    >> Share

  143. MANIAKAS A, Henderson YC, Hei H, Peng S, et al
    Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity.
    J Clin Endocrinol Metab. 2021 Jun 19. pii: 6306517. doi: 10.1210.
    >> Share

  144. TIAN T, Xu Y, Zhang X, Liu B, et al
    Prognostic implications of pre-ablation stimulated Tg: a retrospective analysis of 2500 thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Jun 18. pii: 6304758. doi: 10.1210.
    >> Share

  145. LIMBACH AL, Sipos JA
    Indeterminate thyroid nodules: the hazy genomic landscape coming into focus.
    J Clin Endocrinol Metab. 2021 Jun 16. pii: 6303548. doi: 10.1210.
    >> Share

  146. HENDERSON YC, Mohamed ASR, Maniakas A, Chen Y, et al
    A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Jun 12. pii: 6297567. doi: 10.1210.
    >> Share

    May 2021
  147. HU MI, Waguespack SG, Dosiou C, Ladenson PW, et al
    Afirma Genomic Sequencing Classifier & Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 May 19. pii: 6278308. doi: 10.1210.
    >> Share

  148. SUTEAU V, Seegers V, Munier M, Ben Boubaker R, et al
    G Protein-Coupled Receptors in radioiodine-refractory thyroid cancer in the Era of Precision Medicine.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6277036. doi: 10.1210.
    >> Share

  149. PITT SC, Haymart MR
    Breaking Down or Waking Up? Psychological Distress and Sleep Disturbance in Patients with Thyroid Nodules and Cancer.
    J Clin Endocrinol Metab. 2021 May 13. pii: 6274981. doi: 10.1210.
    >> Share

  150. RAUE F, Bruckner T, Frank-Raue K
    Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma.
    J Clin Endocrinol Metab. 2021 May 11. pii: 6273583. doi: 10.1210.
    >> Share

    April 2021
  151. VALERIO L, Guidoccio F, Giani C, Tardelli E, et al
    [ 18F]-FDG-PET/CT correlates with the response of radiorefractory thyroid cancer to lenvatinib and patients' survival.
    J Clin Endocrinol Metab. 2021 Apr 26. pii: 6253809. doi: 10.1210.
    >> Share

  152. LI R, Li G, Wang Y, Bao T, et al
    Psychological distress and sleep disturbance throughout thyroid nodules screening, diagnosis and treatment.
    J Clin Endocrinol Metab. 2021 Apr 8. pii: 6217326. doi: 10.1210.
    >> Share

    March 2021
  153. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Exceptionality of Distant Metastases in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
    J Clin Endocrinol Metab. 2021 Mar 31. pii: 6206751. doi: 10.1210.
    >> Share

  154. CHERELLA CE, Richman DM, Liu E, Frates MC, et al
    Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Mar 29. pii: 6199870. doi: 10.1210.
    >> Share

  155. LIN YS, Zhang X, Wang C, Liu YQ, et al
    Long-term results of phase II trial of apatinib for progressive radioiodine refractory differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 26. pii: 6189101. doi: 10.1210.
    >> Share

  156. SEO GH, Ae Kong K, Kim BS, Seo YK, et al
    Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-Based Study.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6184125. doi: 10.1210.
    >> Share

  157. WALLNER LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, et al
    Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 4. pii: 6158968. doi: 10.1210.
    >> Share

  158. XI C, Zhang Q, Song HJ, Shen CT, et al
    Pregnancy does not affect the Prognoses of Differentiated Thyroid Cancer Patients with Lung Metastases.
    J Clin Endocrinol Metab. 2021 Mar 1. pii: 6155712. doi: 10.1210.
    >> Share

    February 2021
  159. CHEN DW, Reyes-Gastelum D, Hawley ST, Wallner LP, et al
    Unmet Information Needs Among Hispanic Women with Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154483. doi: 10.1210.
    >> Share

  160. LI CW, Shi X, Ma B, Wang YL, et al
    A Four Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154371. doi: 10.1210.
    >> Share

  161. CESAREO R, Manfrini S, Pasqualini V, Ambrogi C, et al
    Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study).
    J Clin Endocrinol Metab. 2021 Feb 20. pii: 6145113. doi: 10.1210.
    >> Share

  162. ALEXANDER EK
    From the Tip to the Iceberg below - Evolving our Molecular Understanding of Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 Feb 16. pii: 6137555. doi: 10.1210.
    >> Share

  163. CHEN D, Tan Y, Li Z, Li W, et al
    Organoid cultures derived from patients with papillary thyroid cancer.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125726. doi: 10.1210.
    >> Share

    January 2021
  164. PANAGIOTOU G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, et al
    Serum follistatin is increased in thyroid cancer and is associated with adverse tumor characteristics in humans.
    J Clin Endocrinol Metab. 2021 Jan 25. pii: 6119546. doi: 10.1210.
    >> Share

  165. DUTTA S, Tarafdar S, Mukhopadhyay P, Bhattacharyya NP, et al
    Plasma cell free DNA to differentiate malignant from benign thyroid nodules.
    J Clin Endocrinol Metab. 2021 Jan 21. pii: 6105060. doi: 10.1210.
    >> Share

  166. CHONG AS, Nikiforov YE, Condello V, Wald AI, et al
    Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology.
    J Clin Endocrinol Metab. 2021 Jan 18. pii: 6103949. doi: 10.1210.
    >> Share

  167. ZHANG L, Ren Z, Su Z, Liu Y, et al
    Novel recurrent altered genes in Chinese patients with anaplastic thyroid cancer.
    J Clin Endocrinol Metab. 2021 Jan 11. pii: 6082745. doi: 10.1210.
    >> Share

  168. MURPHY CF, Stratford N, Docherty NG, Moran B, et al
    A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
    J Clin Endocrinol Metab. 2021;106:e204-e216.
    >> Share

    December 2020
  169. GRANI G, Lamartina L, AlfO M, Ramundo V, et al
    Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk.
    J Clin Endocrinol Metab. 2020 Dec 30. pii: 6055578. doi: 10.1210.
    >> Share

  170. PITT SC, Yang N, Saucke MC, Marka N, et al
    Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
    J Clin Endocrinol Metab. 2020 Dec 29. pii: 6054975. doi: 10.1210.
    >> Share

  171. ZHU CY, Donangelo I, Gupta D, Nguyen DT, et al
    Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.
    J Clin Endocrinol Metab. 2020 Dec 2. pii: 6015927. doi: 10.1210.
    >> Share

    November 2020
  172. MOON JH, Ryu CH, Cho SW, Choi JY, et al
    Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma.
    J Clin Endocrinol Metab. 2020 Nov 28. pii: 6009064. doi: 10.1210.
    >> Share

  173. CAPEZZONE M, Sagnella A, Pilli T, Maino F, et al
    Role of Age at Diagnosis in Defining Potential Familial Non-Medullary Thyroid Cancer in Kindreds with Only Two Affected Members.
    J Clin Endocrinol Metab. 2020 Nov 11. pii: 5974121. doi: 10.1210.
    >> Share

    October 2020
  174. WASSNER AJ
    Risk Stratification in Pediatric Thyroid Cancer: Growing Evidence for Individualized Therapy.
    J Clin Endocrinol Metab. 2020 Oct 30. pii: 5943497. doi: 10.1210.
    >> Share

  175. BROOME DT, Naples R, Bailey R, Tekin Z, et al
    Use of Preoperative Imaging in Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2020 Oct 29. pii: 5942949. doi: 10.1210.
    >> Share

  176. YANG S, Jin C, Xu X
    Letter to the Editor from Shijie Yang et al: US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study.
    J Clin Endocrinol Metab. 2020 Oct 22. pii: 5936021. doi: 10.1210.
    >> Share

    September 2020
  177. SHI X, Li CW, Tan LC, Wen SS, et al
    Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3 and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    J Clin Endocrinol Metab. 2020 Sep 30. pii: 5916419. doi: 10.1210.
    >> Share

  178. RINGEL MD
    New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
    J Clin Endocrinol Metab. 2020 Sep 25. pii: 5911817. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016